Tagged with P

Algeria Sofiane Achi of El Kendi, one of Algeria’s leading pharma manufacturers, discusses the fresh ideas he has brought back to the company following a stint at Boehringer Ingelheim, manufacturing upgrades, and the country’s readiness for biosimilars. You decided to return to a company that you already know very well. How…

Cyprus Christoforos Hadjikyprianou of the European University Cyprus, home to the island’s only state-of-the-art medical school, explains the institution’s unique value proposition and his vision for the future. Could you introduce yourself as well as European University Cyprus? “In the last decade-and-a-half we have made huge strides.” I am the University’s…

Cyprus Polis Peratikos of the Cyprus Health Services Promotion Board leads the operation promoting the healthcare tourism capabilities of Cyprus across the world, notably in the UK and Russia. In this interview he introduces healthcare villages, their scope of operations, and why the time to invest in Cyprus is now. Could…

Turkey Renan Ozyerli of MSD Turkey provides insights into the transformation of Turkey’s healthcare ecosystem over the past decade, highlighting how MSD works hand-in-hand with the government to broaden access to life-changing innovation. He also pinpoints MSD’s exceptional and enduring commitment to Turkey, which has led the company to emerge as…

Spain Reig Jofre’s Ignasi Biosca outlines recent changes at the Spanish family-owned company, preserving its original ethos, portfolio development and internationalization plans. Can you update us on some of the recent changes at Reig Jofre? “The family still maintains 72 percent of the shares of the company so the original corporate…

UK Dr. Geoffrey Guy, chairman and founder of cannabinoid medicine pioneer, GW Pharma, outlines the potential benefits that Brexit could bring to the UK’s life sciences industry and the evolution of his company. Unlike many of your peers, you are very optimistic about Brexit. What opportunities do you believe Brexit will…

Portugal Joaquim Chaves, CEO of Basi Laboratories, presents the Basi production success story to readers. Located in Mortágua, two hours north of Portugal’s third city, Coimbra, the vast production site recently received 40 million euros of investment for manufacturing expansion and has strong intentions to increase the scope of their internationalization…

Hong Kong Gene Shigekawa, managing partner of MAZ World, shares their recent move to the Hong Kong Science and Technology Park (HKSTP) in 2017, the revolutionary ostrich-derived antibody they hope to further develop and commercialize, the strengths of Hong Kong as a biotech base for start-ups, and the huge potential for their…

Brexit The European Medicines Agency has cut Britain out of its contracts 7 months ahead of Brexit. “You might have been working on a cancer drug for decades and built up so much expertise that you are the absolute specialist in your field and now have to transfer all your knowledge…

Spain Dr. Carlos Macaya, one of the world’s most renowned cardiologists and president of the Spanish Heart Foundation (FEC), outlines the landscape for cardiovascular disease in Spain. Could you please start by introducing yourself? We understand that you are renowned for having operated on Mother Teresa. “I have participated in over…

Algeria Dr. Zoubir Harrat heads the Institut Pasteur d’Algérie (IPA), after having spent most of his career with the institution. He talks of the importance to prepare for the healthcare challenges of the future, and how the only way to achieve this is through collaboration and training of future generations.  …

Hong Kong Professor Hon-Ming Lam, a renowned scientist specializing in soybean genomics, shares his passion for his research, the importance of soybeans to China’s future environmental and growth sustainability, his insights on Hong Kong’s ambition to become an innovation and technology hub, and his perspective on how government, industry and academics should…